Who decides the cost of medicines in India?
India’s separation of medicine licensing under CDSCO and pricing under NPPA presents a policy challenge. Stronger coordination,supported by pharmaceutical, clinical and health-economic expertise, could bridge this gap
Read the full story at source →
Post Comment